IgG-RFB4-SMPT-dgA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IgG-RFB4-SMPT-dgA, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma [Phase 1]